MASSIMI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 871
AS - Asia 487
EU - Europa 376
AF - Africa 134
SA - Sud America 109
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 1.990
Nazione #
US - Stati Uniti d'America 799
SG - Singapore 188
CN - Cina 89
IT - Italia 86
BR - Brasile 62
HK - Hong Kong 48
VN - Vietnam 42
DE - Germania 37
RU - Federazione Russa 30
NL - Olanda 29
FI - Finlandia 26
GB - Regno Unito 26
FR - Francia 19
BJ - Benin 13
IE - Irlanda 11
JP - Giappone 11
MX - Messico 10
PL - Polonia 10
AR - Argentina 9
CA - Canada 9
PH - Filippine 9
AT - Austria 8
CO - Colombia 8
EC - Ecuador 8
ES - Italia 8
LA - Repubblica Popolare Democratica del Laos 8
MG - Madagascar 8
AE - Emirati Arabi Uniti 7
IN - India 7
ML - Mali 7
SE - Svezia 7
HN - Honduras 6
KE - Kenya 6
MR - Mauritania 6
SN - Senegal 6
AO - Angola 5
BB - Barbados 5
BE - Belgio 5
BY - Bielorussia 5
CG - Congo 5
CW - ???statistics.table.value.countryCode.CW??? 5
JM - Giamaica 5
LB - Libano 5
LV - Lettonia 5
MU - Mauritius 5
NE - Niger 5
NI - Nicaragua 5
PE - Perù 5
TR - Turchia 5
BA - Bosnia-Erzegovina 4
BF - Burkina Faso 4
BW - Botswana 4
DK - Danimarca 4
DM - Dominica 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GR - Grecia 4
HR - Croazia 4
ID - Indonesia 4
JO - Giordania 4
KR - Corea 4
KZ - Kazakistan 4
ME - Montenegro 4
MW - Malawi 4
MZ - Mozambico 4
NO - Norvegia 4
PK - Pakistan 4
PR - Porto Rico 4
PT - Portogallo 4
PY - Paraguay 4
RS - Serbia 4
RW - Ruanda 4
SI - Slovenia 4
TW - Taiwan 4
ZA - Sudafrica 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
AZ - Azerbaigian 3
BS - Bahamas 3
BZ - Belize 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
GA - Gabon 3
GF - Guiana Francese 3
GM - Gambi 3
IL - Israele 3
IQ - Iraq 3
IR - Iran 3
MK - Macedonia 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UA - Ucraina 3
VE - Venezuela 3
AU - Australia 2
BD - Bangladesh 2
BO - Bolivia 2
Totale 1.909
Città #
Ashburn 125
Singapore 120
Fairfield 101
Chandler 77
Hong Kong 47
Beijing 36
Cambridge 33
Santa Clara 33
Seattle 30
Woodbridge 30
San Jose 28
San Diego 26
Padova 24
Houston 22
Helsinki 18
Ho Chi Minh City 14
Cotonou 13
Hanoi 13
Wilmington 13
Boardman 12
Medford 12
Princeton 12
Munich 11
São Paulo 11
Los Angeles 10
New York 10
Norwich 10
Ann Arbor 9
Chicago 9
Des Moines 9
Milan 9
Nuremberg 9
Roxbury 8
Amsterdam 7
Bytom 7
Vientiane 7
Antananarivo 6
Dublin 6
Nairobi 6
Bamako 5
Bridgetown 5
Curtarolo 5
Dakar 5
Lappeenranta 5
London 5
Luanda 5
Managua 5
Manila 5
Menlo Park 5
Minsk 5
Niamey 5
Nouakchott 5
Orem 5
Rome 5
Tokyo 5
Vienna 5
Amman 4
Buffalo 4
Denver 4
Frankfurt am Main 4
Kigali 4
Maputo 4
Mexico City 4
Montreal 4
Quito 4
Willemstad 4
Almaty 3
Baghdad 3
Baku 3
Bogotá 3
Boston 3
Brazzaville 3
Brooklyn 3
Brussels 3
Dallas 3
Falkenstein 3
Istanbul 3
Johannesburg 3
Kingston 3
Kyiv 3
Libreville 3
Lilongwe 3
Ljubljana 3
Moscow 3
Nassau 3
Ouagadougou 3
Podgorica 3
Pune 3
Riga 3
Rio de Janeiro 3
Roseau 3
San Francisco 3
Sharjah 3
Tel Aviv 3
Verona 3
Washington 3
Abidjan 2
Accra 2
Addis Ababa 2
Athens 2
Totale 1.206
Nome #
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 224
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 186
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 185
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 185
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 182
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 172
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 171
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 168
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation 148
Medical and gastroenterological education during the COVID-19 outbreak 136
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study 135
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study 125
Totale 2.017
Categoria #
all - tutte 7.433
article - articoli 7.433
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 6 7 15 6 5 11
2021/2022235 14 16 27 7 17 40 17 4 30 18 11 34
2022/2023155 20 2 14 26 22 19 2 15 17 1 9 8
2023/2024131 10 13 15 10 14 17 15 11 2 4 11 9
2024/2025412 1 30 21 13 44 18 24 43 40 25 46 107
2025/2026944 93 109 209 232 154 94 53 0 0 0 0 0
Totale 2.017